David R. Venturella

Representative Experience

• Tennessee Oncology and General Atlantic Create OneOncology
  We represented Tennessee Oncology in the launch of OneOncology in affiliation with global private equity firm General Atlantic. OneOncology is...
  Read More
  Client Type: Private Company
• Engility Holdings to Merge with SAIC for $2.5 Billion

  Engility Holdings to Merge with SAIC for $2.5 Billion

  We are representing Engility Holdings (NYSE: EGL) in its definitive agreement to merge with Science Applications International Corp. (NYSE: SAIC)...
  Read More
  Client Type: Public Company
• i3 Verticals, Inc. 2018 Initial Public Offering

  Represented i3 Verticals, Inc. in its initial public offering (IPO) of of 7,647,500 shares of Class A common stock for a total net proceeds of $92.5 million.

  We represented i3 Verticals, Inc. in its initial public offering (IPO) of 7,647,500 shares of Class A common stock for...
  Read More
  Client Type: Public Company
• i3 Verticals, Inc. 2018 Initial Public Offering

  Represented i3 Verticals, Inc. in its initial public offering (IPO) of of 7,647,500 shares of Class A common stock for a total net proceeds of $92.5 million.

  We represented i3 Verticals, Inc. in its initial public offering (IPO) of 7,647,500 shares of Class A common stock for...
  Read More
  Client Type: Public Company
• Addus HomeCare Acquires Arcadia Home Care & Staffing

  Represented Addus HomeCare Corporation (Nasdaq: ADUS) in its acquisition of Arcadia Home Care & Staffing.

  We represented Addus HomeCare Corporation (Nasdaq: ADUS) in its acquisition of Arcadia Home Care & Staffing, a Michigan-based provider of...
  Read More
  Client Type: Public Company
• Pharos Capital Launches Verdi Oncology through Horizon Oncology Acquisition

  Represented Pharos Capital Group in its acquisition of Horizon Oncology

  We represented Pharos Capital Group in its acquisition of Horizon Oncology. The acquisition marks the launch of Verdi Oncology, Inc.,...
  Read More
  Client Type: Private Company
• Pharos Capital’s Family Treatment Network Acquires Behavior Care Specialists

  Represented Family Treatment Network in its acquisition of Behavioral Care Specialists

  We represented Family Treatment Network (FTN), a portfolio company of Pharos Capital Group, in its acquisition of Behavioral Care Specialists...
  Read More
  Client Type: Private Company
• ISA Sold to Align Capital Partners

  We represented International Systems of America, LLC (ISA), a portfolio company of Gen Cap America, in its sale to Align Capital Partners.

  We represented International Systems of America, LLC (ISA), a portfolio company of Gen Cap America, in its sale to Align...
  Read More
  Client Type: Private Company
• $167.5 Million Disposition of Extended Care Solutions Business

  Represented Change Healthcare in its $167.5 million disposition of extended care solutions business to Netsmart

  We represented Change Healthcare in its $167.5 million disposition of the legacy extended care solutions business of McKesson to Netsmart....
  Read More
  Client Type: Public Company